
Jupiter Life Line (JLHL) | Stock Overview & Key Data
Jupiter Life Line Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,770.00 on March 24, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Jupiter Life Line JLHL | 91.21B Mid-cap | -0.75% | -3.88% | 1.16% | -3.54% | -5.96% | 6.06% | 35.26% | 35.26% |
Max Healthcare MAXHEALTH | 1.23T Large-cap | 1.03% | 3.62% | 8.91% | 23.86% | 10.85% | 42.72% | 233.37% | 1,030.47% |
Apollo Hospitals APOLLOHOSP | 1.04T Large-cap | -0.67% | 0.97% | 4.81% | 14.91% | -1.50% | 8.56% | 75.54% | 332.73% |
Rainbow Children's RAINBOW | 149.13B Mid-cap | 0.09% | -1.53% | 11.20% | 14.78% | -3.26% | 25.64% | 158.87% | 244.50% |
Healthcare Global HCG | 90.15B Mid-cap | 6.59% | 16.54% | 13.21% | 31.47% | 34.34% | 83.02% | 129.99% | 405.86% |
Kovai Medical Center KOVAI | 68.25B Mid-cap | 3.90% | 2.36% | 13.36% | 16.52% | 4.29% | 28.53% | 331.20% | 754.25% |
Ownership & Short Interest
Jupiter Life Line Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Jupiter Life Line would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is JLHL's 52-week high and low?
- In the last 52 weeks, Jupiter Life Line reached a high of ₹1,770.00 (on March 25, 2025) and a low of ₹1,263.20 (on September 20, 2024).
- What is the market cap and P/E ratio for JLHL?
- Curious about Jupiter Life Line's size and valuation? Its market capitalization stands at 91.21B. When it comes to valuation, the P/E ratio (trailing twelve months) is 47.40, and the forward P/E (looking ahead) is 36.55.
- Does JLHL pay dividends? If so, what's the yield?
- Yes, Jupiter Life Line is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.13%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Jupiter Life Line's main competitors or similar companies to consider before investing?
When looking at Jupiter Life Line, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.23T Healthcare Medical Care Facilities 42.72% 233.37% Apollo Hospitals
APOLLOHOSP1.04T Healthcare Medical Care Facilities 8.56% 75.54% Rainbow Children's
RAINBOW149.13B Healthcare Medical Care Facilities 25.64% 158.87% Healthcare Global
HCG90.15B Healthcare Medical Care Facilities 83.02% 129.99% Kovai Medical Center
KOVAI68.25B Healthcare Medical Care Facilities 28.53% 331.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Jupiter Life Line Hospitals Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Jupiter Life Line's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.27%, the Debt to Equity ratio from the most recent quarter is 28.99, and its Gross Profit Margin stands at 80.33%.
- What is the recent revenue and earnings growth for JLHL?
- Looking at Jupiter Life Line's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.10%, and quarterly earnings saw a YoY growth of -1.70%.
- How much of JLHL stock is held by insiders and institutions?
- Wondering who owns Jupiter Life Line stock? Company insiders (like executives and directors) hold about 65.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 18.40%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.